top of page

Nanozymes: IISc’s Breakthrough Against Deadly Blood Clots

ree

In a major advancement in medical science, researchers at the Indian Institute of Science (IISc) have developed a vanadium pentoxide (V₂O₅)-based nanozyme that can potentially prevent abnormal blood clotting in conditions like pulmonary thromboembolism (PTE).


What is Pulmonary Thromboembolism (PTE)?

  • PTE occurs when blood clots block arteries in the lungs, often due to overactivation of platelets.

  • While clotting is essential to prevent bleeding, excessive clotting (thrombosis) can be fatal.


Role of the Nanozyme

  • The IISc-developed metal-based nanozyme mimics natural enzymes to regulate platelet activation.

  • V₂O₅ nanozyme can control the clotting cascade, reducing the risk of mortality from PTE.


What are Nanozymes?

  • Nanozymes = Nanomaterials with enzyme-like properties

  • Function like natural enzymes but offer benefits such as:

    • High stability

    • Low cost

    • Easy mass production

    • High catalytic activity


UPSC Relevance

  • GS Paper 3: Science & Tech – Nanotechnology and its applications in healthcare

  • GS Paper 2: Government support for scientific innovation and research

  • Essay/GS4: Innovation in Public Health & Ethics in Scientific Research


📘 Prelims Practice Question (UPSC CSE Type):

Q. With reference to nanozymes, consider the following statements:

  1. They are synthetic compounds designed to inhibit platelet formation.

  2. They possess enzyme-like catalytic properties.

  3. They can be used in treating thrombosis and other clotting disorders.

Which of the statements given above is/are correct?

A. 1 and 2 only

B. 2 and 3 only

C. 1 and 3 only

D. 1, 2 and 3


Answer: B. 2 and 3 only

Explanation:

  • Statement 1 is incorrect: Nanozymes are not specifically designed just to inhibit platelets, but mimic enzyme functions for broader uses.

  • Statement 2 is correct: Nanozymes show enzyme-like catalytic activity.

  • Statement 3 is correct: They show promise in managing thrombosis and clotting disorders, as demonstrated by IISc's V₂O₅ nanozyme.


✍️ Mains Practice Question (GS Paper 3):

What are nanozymes? Discuss their advantages over natural enzymes and their potential in addressing critical healthcare challenges like thrombosis.


 
 
 

Comments


bottom of page